#ICYMI: Watch this episode of Tuesday Talks, where we discussed whether AI can revolutionize medicine by enhancing drug development efficiency, accuracy, and cost-effectiveness. Cure and The New York Academy of Sciences with Nicholas Dirks brought together a panel of experts, including George Church of Harvard University, Maria Luisa Pineda, PhD. of Envisagenics, Grant W Mitchell, MD, MBA, of Every Cure, and Thomas Fuchs of Icahn School of Medicine at Mount Sinai who discussed AI's transformative role in bringing patients more effective treatments faster. #aiforgood #wewillcure
关于我们
Cure is a vibrant healthcare innovation campus in the heart of New York City with a mission to advance health. Supporting healthcare and life science entrepreneurs, Cure offers digital and in-person content, programming, and learnings on critical health and business topics. The campus at 345 Park Avenue South features laboratory and business facilities, office space and premium event venues, including an education center, conference center, and iconic rooftop terrace. Residents and members collaborate across the spectrum of healthcare and focus on diagnostic, device, drug development and production as well as care delivery and public health. For more information, please visit wewillcure.com.
- 网站
-
www.wewillcure.com
Cure.的外部链接
- 所属行业
- 健康与公共事业
- 规模
- 11-50 人
- 总部
- New York,NY
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Life Science、Incubator、Fellowships、healthcare、scientists、doctors、researchers、digitalhealth、science、health、startup、doctors 、ecosystems、business、AI、education、cancer、entreprenuer、health equity、access to care、global health、artificial intelligence、events和start-ups
地点
-
主要
345 Park Ave S
US,NY,New York,10010
Cure.员工
-
David Ewing Duncan
Journalist, Author, Researcher, Curator, and Advisor
-
Lauren Ruotolo
Creative Media Partnerships & Executive Producer | Keynote Speaker | Disability Advocate
-
Paul Oestreicher
Strategic Communications; Public and Media Relations; Risk/Issues/Crisis/Reputation Management; Thought Leader; Mentor, and Trusted…
-
Charles Kim
COO & CFO | Healthcare, Sustainability, Food & Beverage
动态
-
Cure asked Jessica J. Federer, MPH, if we have sufficient data on women's health or if a significant gender gap still exists. Watch to uncover the alarming data gaps in women's healthcare research. #womenshealth #gendergap #biofuture2024
-
Sergei Petukhov, DVM co-founder and CEO of Metallomix Inc. a Cure resident company that is developing disease-modifying drugs based on isotopically modified zinc for the treatment of diseases such as cancer, neurodegenerative diseases and metabolic disorders. Read more to find out Petukhov’s five essential tips for biotech entrepreneurs on building a resilient company. https://lnkd.in/dvc5RNW8
-
Greg Simon the former leader of President Biden's Cancer Moonshot, believes that saving lives depends less on new technologies and more on effective access to existing ones.?Read more to discover his insights on what the future of?the healthcare market might look like. https://lnkd.in/ezdar-qE
Simon Calls for Healthcare Reform Focused on Accessibility
wewillcure.com
-
With women representing 51% of the U.S. population, why does their healthcare continue to lag in technology, policy, and education? Join us next week for Tuesday Talks with the inspiring Jessica J. Federer, MPH, a globally recognized leader in digital transformation and health technologies! Cure CEO?Seema Kumar?sat down with Jessica during?#biofuture2024,?produced by Demy-Colton,?to discuss the critical challenges that still stand in the way of true progress in women’s health research. Don’t miss this eye-opening conversation! #linkedinlive #womenshealth
Tuesday Talks: The Real Challenges of the Healthcare Research Gender Gap
www.dhirubhai.net
-
Stephen Klasko, Executive In Residence at General Catalyst is transforming health equity and payer-provider relationships by risk-taking, creating new partnerships, and shifting current cultures. Read more: https://lnkd.in/efy8nbmS
Stephen Klasko on Disrupting Healthcare Systems to Improve
wewillcure.com
-
#ICYMI, Watch Kevin J. Tracey, MD, the founding father of bioelectronic medicine and the President of The Feinstein Institutes at Northwell Health. Cure CEO?Seema Kumar?sat down with Tracey during #biofuture2024,?produced by Demy-Colton,?where he discussed the latest advances in bioelectronic medicine and how these innovations could transform disease management using electrical pulses instead of drugs.?Watch Now!
ICYMI: Why Bioelectronic Medicine Could Transform Chronic Disease Treatment
www.dhirubhai.net
-
Mark your calendar ?? for next week’s Tuesday Talks with Kevin J. Tracey, MD, president of The Feinstein Institutes for Medical Research at Northwell Health. Tracey, known as the founding father of bioelectronic medicine, sat down with Cure CEO?Seema Kumar?during #biofuture2024,?produced by Demy-Colton,?where he explored the latest advances in bioelectronic medicine and how these innovations could transform disease management using electrical pulses instead of drugs. Register today!
Why Bioelectronic Medicine Could Transform Chronic Disease Treatments
www.dhirubhai.net
-
With over 40,000 children diagnosed with congenital heart defects each year in the U.S., the need for specialized medical devices is urgent. Shockingly, 63% of pediatric interventional cardiology procedures rely on off-label devices, which are often intended for adults. CobiCure, is a resident company at Cure, a nonprofit advancing innovation of urgently needed pediatric medical devices. ? To learn more about how CobiCure is transforming the future of pediatric healthcare and why?Emma Moran, PhD, Director of Strategy and Development, emphasizes the urgent issue of underfunding and lack of attention in pediatric medical technologies, read further. #wewillcure https://lnkd.in/ecqHqfWX
CobiCure MedTech Helps Mend Tiny Hearts
wewillcure.com
-
Despite women making up more than half of the population, advancements in women’s health remain overlooked and underfunded. Read more on why companies like DeepLook Medical, Butterfly Network, Inc., and Health In Her HUE, are all part of the often-undervalued field of “femtech" and the shifts needed to create a healthcare innovation landscape where femtech companies that benefit women can thrive. #wewillcure #femtech #womenshealth
5 Things Needed for Femtech to Flourish
wewillcure.com